BIOMAT Database Logo BIOMAT Database Logo

[Transurethral enucleation and resection versus transurethral resection of the prostate in the treatment of high-risk benign prostatic hyperplasia]. 2020

Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
Department of Urology, People's Hospital of Hainan Province, Hainan Affiliated Hospital of Hainan Medical University Haikou，Haikou, Hainan 570311, China.

OBJECTIVE To investigate the clinical effect of transurethral enucleation and resection of the prostate (TUERP) versus that of transurethral resection of the prostate (TURP) in the treatment of high-risk BPH. METHODS From June 2018 to December 2018, a total of 60 patients with high-risk BPH were randomly assigned to receive TUERP (n = 30) or TURP (n = 30). Comparisons were made between the two groups of patients in the operation time, intraoperative blood loss, volume of the resected prostate, and postoperative complications. RESULTS Compared with the patients treated by TURP, those in the TUERP group showed a significantly shorter operation time(［76.2±15.9］ min vs ［47.5±16.1］ min, P < 0.05), less intraoperative blood loss(［93.7±33.6 vs ［60.5±25.4］ ml］ ml, P < 0.05), but a larger volume of the resected prostate(［30.6±8.5］ g vs ［42.3±12.2］ g, P < 0.05)， and a less incidence of postoperative complications, such as secondary bleeding, uracratia and urethrostenosis. CONCLUSIONS Both TUERP and TURP are clinically effective for the treatment of high-risk BPH, but TUERP is even better than TURP for its advantages of shorter operation time, less intraoperative blood loss, larger volume of resected prostate, fewer postoperative complications, and less surgical trauma.

UI MeSH Term Description Entries
D008297 Male Males
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016063 Blood Loss, Surgical Loss of blood during a surgical procedure. Hemorrhage, Surgical,Surgical Blood Loss,Surgical Hemorrhage,Surgical Blood Losses,Surgical Hemorrhages
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D061646 Operative Time The duration of a surgical procedure in hours and minutes. Length of Operative Time,Surgical Time,Time Length of Surgery,Operative Time Length,Operative Time Lengths,Operative Times,Surgery Time Length,Surgery Time Lengths,Surgical Times,Time Length, Operative,Time Lengths, Operative,Time, Operative,Time, Surgical,Times, Operative,Times, Surgical
D020728 Transurethral Resection of Prostate Removal of all or part of the PROSTATE, often using a cystoscope and/or resectoscope passed through the URETHRA. Contact Laser Ablation of Prostate,Prostatectomy, Transurethral,TURP,TUVP,Transurethral Electroresection of Prostate,Transurethral Electrovaporization of Prostate,Transurethral Microwave Thermotherapy,Transurethral Needle Ablation of Prostate,Transurethral Radiofrequency Thermal Ablation,Transurethral Thermotherapy,Transurethral Ultrasound-Guided Laser-Induced Prostatectomy,Transurethral Vaporesection of Prostate,Transurethral Visual Laser Ablation of Prostate,VLAP,Transurethral Prostate Resection,Microwave Thermotherapy, Transurethral,Prostate Resection, Transurethral,Prostate Resections, Transurethral,Prostate Transurethral Electroresection,Prostate Transurethral Electroresections,Prostate Transurethral Electrovaporization,Prostate Transurethral Electrovaporizations,Prostate Transurethral Resection,Prostate Transurethral Resections,Prostate Transurethral Vaporesection,Prostate Transurethral Vaporesections,Prostatectomies, Transurethral,Resection, Transurethral Prostate,Resections, Transurethral Prostate,TURPs,Thermotherapies, Transurethral,Thermotherapy, Transurethral,Thermotherapy, Transurethral Microwave,Transurethral Prostate Resections,Transurethral Prostatectomies,Transurethral Prostatectomy,Transurethral Thermotherapies,Transurethral Ultrasound Guided Laser Induced Prostatectomy

Related Publications

Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
[Transurethral diode laser enucleation versus transurethral electrovaporization resection of the prostate for benign prostatic hyperplasia with different prostate volumes].
March 2017, Zhonghua nan ke xue = National journal of andrology,
Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
[Shovel-shaped electrode transurethral plasmakinetic enucleation versus plasmakinetic resection of the prostate in the treatment of benign prostatic hyperplasia].
February 2018, Zhonghua nan ke xue = National journal of andrology,
Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
[Transurethral resection of the prostate versus transurethral holmium laser enucleation of the prostate for benign prostatic hyperplasia with bladder detrusor overactivity].
August 2016, Zhonghua nan ke xue = National journal of andrology,
Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
[Transurethral plasmakinetic enucleation of the prostate for benign prostatic hyperplasia].
May 2011, Zhonghua nan ke xue = National journal of andrology,
Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
Transurethral thulium laser enucleation versus resection of the prostate for treating benign prostatic hyperplasia: a retrospective study.
March 2019, Lasers in medical science,
Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
Laser prostatectomy versus transurethral resection of prostate in the treatment of benign prostatic hyperplasia.
January 2007, Saudi medical journal,
Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
Prostatic Arterial Embolization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia.
July 2015, Radiology,
Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
Transurethral enucleation of benign prostatic hyperplasia.
November 1989, The Journal of urology,
Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
Transurethral enucleation of benign prostatic hyperplasia.
April 1986, Nihon Ika Daigaku zasshi,
Hou-Sheng Fu, and Fei Wang, and An-Fang Wang, and Xin-Li Kang
Technical aspects of transurethral plasmakinetic enucleation and resection of the prostate for benign prostatic hyperplasia.
February 2017, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy,
Copied contents to your clipboard!